EcoSynthetix (ECO) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Q4 2024 sales rose 91% year-over-year to $5.4 million, with annual sales up 46% to $18.5 million, driven by strong volume growth across all end markets.
Volume demand rose 82% in Q4 and 56% for the full year, reflecting broad-based growth.
Adjusted EBITDA turned positive at $0.1M in Q4 2024, up from a loss of $(1.0)M in Q4 2023; annual Adjusted EBITDA loss narrowed to $(0.9)M from $(2.5)M.
Strategic progress was made in pulp, wood composites, personal care, packaging, and tissue, including a significant $1.1 million commercial order from an international pulp manufacturer.
Maintained strong liquidity with $32.2M in cash and term deposits at year-end.
Financial highlights
Net sales grew 91% year-over-year in Q4 and 46% for the full year, reaching $5.4M and $18.5M, respectively.
Gross profit increased to $1.6M in Q4 2024 and $5.3M for FY 2024, with gross margin rising to 34.4% in Q4 and 33.2% for the year.
Adjusted EBITDA was $90,000 in Q4 (up $1.1M YoY); annual adjusted EBITDA loss was $860,000, an improvement of $1.7M YoY.
Cash provided by operations was $1.1M for the year, with $32.2M in cash and term deposits at year-end.
SG&A: $1.8M in Q4, $6.5M for the year, up due to FX losses, compensation, and asset relocation.
Outlook and guidance
Some softness in base business volume demand noted in early 2025 amid a challenging industrial climate.
Growth expected to be driven by pulp, wood composites, packaging, and tissue, with personal care as a supplementary driver.
Company maintains capacity to scale business to $100 million in sales before requiring new facilities.
Management expects continued growth in 2025, supported by momentum in pulp and wood composites markets and expanded applications in personal care.
Focus remains on converting strategic prospects and scaling commercial operations with key customers.
Latest events from EcoSynthetix
- Q2 2026 revenue dropped 9% to $4.5M, with losses but strong cash and ongoing market activity.ECO
Q2 202629 Jul 2026 - Q3 2024 sales rose 38% with positive EBITDA, strong cash flow, and broad-based market momentum.ECO
Q3 20248 Jul 2026 - Sales fell 7% in Q1 2026, but margin gains and trial activity point to H2 growth.ECO
Q1 20266 May 2026 - Double-digit sales growth, margin expansion, and record strategic market demand in 2025.ECO
Q4 202520 Feb 2026 - Sales and margins improved, with new wins and strong cash reserves driving growth.ECO
Q2 20242 Feb 2026 - Q1 2025 sales declined 14%, but strategic wins and strong liquidity support long-term growth.ECO
Q1 202526 Nov 2025 - Q2 2025 net sales rose 57% with positive adjusted EBITDA and strong liquidity from market wins.ECO
Q2 202516 Nov 2025 - Q3 2025 sales up 11% to $5.8M, with strong growth and liquidity in key end markets.ECO
Q3 20257 Nov 2025